Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
- Submitting institution
-
University of Wolverhampton
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 1328
- Type
- D - Journal article
- DOI
-
10.1038/leu.2017.111
- Title of journal
- Leukemia
- Article number
- -
- First page
- 2435
- Volume
- 31
- Issue
- 11
- ISSN
- 0887-6924
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
https://static-content.springer.com/esm/art%3A10.1038%2Fleu.2017.111/MediaObjects/41375_2017_BFleu2017111_MOESM81_ESM.docx
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
18
- Research group(s)
-
-
- Citation count
- 12
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the organisation of the conduct of the study and to carrying out the study. The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -